Caoyun Ju

Dr. Caoyun Ju

State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing 210009, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MHMeixi Hao
Meixi Hao
SHSiyuan Hou
Siyuan Hou
WLWeishuo Li
Weishuo Li
KLKaiming Li
Kaiming Li
LXLingjing Xue
Lingjing Xue
CZCan Zhang
Can Zhang
Treatment of solid tumors with T cell therapy has yielded limited therapeutic benefits to date. Although T cell therapy in combination with proinflammatory cytokines or immune checkpoints inhibitors has demonstrated preclinical and clinical successes in a subset of solid tumors, unsatisfactory results and severe toxicities necessitate the development of effective and safe combinatorial strategies. Here, the liposomal avasimibe (a metabolism-modulating drug) was clicked onto the T cell surface by lipid insertion without disturbing the physiological functions of the T cell. Avasimibe could be restrained on the T cell surface during circulation and extravasation and locally released to increase the concentration of cholesterol in the T cell membrane, which induced rapid T cell receptor clustering and sustained T cell activation. Treatment with surface anchor-engineered T cells, including mouse T cell receptor transgenic CD8+ T cells or human chimeric antigen receptor T cells, resulted in superior antitumor efficacy in mouse models of melanoma and glioblastoma. Glioblastoma was completely eradicated in three of the five mice receiving surface anchor-engineered chimeric antigen receptor T cells, whereas mice in other treatment groups survived no more than 64 days. Moreover, the administration of engineered T cells showed no obvious systemic side effects. These cell-surface anchor-engineered T cells hold translational potential because of their simple generation and their safety profile.

1 August 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
XCXinyan Chen
Xinyan Chen
YZYidi Zhang
Yidi Zhang
CTChunming Tang
Chunming Tang
CTChunli Tian
Chunli Tian
QSQiong Sun
Qiong Sun
CZCan Zhang
Can Zhang

1 February 2020 in Carbohydrate Polymers
Verified
Journal Article
Closed access
DQDing Qu
Ding Qu
MJMengying Jiao
Mengying Jiao
HLHaijiao Lin
Haijiao Lin
CTChunli Tian
Chunli Tian
GQGuowei Qu
Guowei Qu
CZCan Zhang
Can Zhang

1 March 2019 in Carbohydrate Polymers
Verified
Journal Article
Closed access
GQGuowei Qu
Guowei Qu
SHSiyuan Hou
Siyuan Hou
DQDing Qu
Ding Qu
CTChunli Tian
Chunli Tian
JZJingcheng Zhu
Jingcheng Zhu
CZCan Zhang
Can Zhang

1 December 2020 in Journal of Controlled Release
Verified
Journal Article
Closed access
WLWeishuo Li
Weishuo Li
ZSZhigui Su
Zhigui Su
MHMeixi Hao
Meixi Hao
CJCaoyun Ju
Caoyun Ju
CZCan Zhang
Can Zhang

2 June 2021 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
CTChunming Tang
Chunming Tang
QWQianqian Wang
Qianqian Wang
KLKaiming Li
Kaiming Li
XLXiuqi Li
Xiuqi Li
CWCong Wang
Cong Wang
CZCan Zhang
Can Zhang
Neuroinflammation plays a key role in the progression of brain injury induced by stroke, and has become a promising target for therapeutic intervention for stroke. Monitoring this pivotal process of neuroinflammation is highly desirable to guide specific therapy. However, there is still a lack of a satisfactory nanoprobe to selectively monitor neuroinflammation. As endothelial cell activation is a hallmark of neuroinflammation, it would be clinically relevant to develop a non-invasive in vivo imaging technique to detect the endothelial activation process. Herein, inspired by the specific neutrophil–endothelium interaction, we designed neutrophil-camouflaged magnetic nanoprobes (NMNPs) that can be used to target activated endothelial cells for improved neuroinflammation imaging. NMNPs are composed of an inner core of superparamagnetic iron oxide (SPIO)-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles and a biomimetic outer shell of a neutrophil membrane, which maintained the biocompatibility and targeting ability of neutrophils and the excellent contrast effects of SPIO. Moreover, we demonstrated that NMNPs can successfully bind to inflamed cerebral vasculature using the intravital imaging of live cerebral microvessels in transient middle cerebral artery occlusion (tMCAO) mice. After that, NMNPs could further accumulate in the brain vasculature and exhibit excellent contrast effects for stroke-induced neuroinflammation and biosafety. We believe that the neutrophil-camouflaged magnetic nanoprobe could serve as a highly safe and selective nanoprobe for neuroinflammation imaging and has alluring prospects for clinical application.